Sohm(OTC) SHMN

Market Cap$2.44M

Since IPO (2006)-100%

5 Year-81%

1 Year-38%

1 Month-18%

$0.00

+0.00%

+0.00Today

Sohm last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-13

Sohm stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-06
1 month	-18.18%	USD 0.00	2026-07-14
3 month	-18.18%	USD 0.00	2026-05-14
Year to date	+0%	USD 0.00	2025-12-31
1 year	-37.93%	USD 0.00	2025-08-13
3 year	-10%	USD 0.00	2023-08-14
5 year	-81.25%	USD 0.00	2021-08-13
Since inception	-100%	USD 75.00	2006-10-11

Sohm Financials at a Glance

Market Cap

$2.44M

Revenue (TTM)

$1.10M

Net Income (TTM)

-$735.42K

EPS (TTM)

-$0.00

P/E Ratio

-3.00

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$0.00

Volume

120,001

Open

$0.00

Price

$0.00

Volume

120,001

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 14, 2024

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$0.00

Volume

120,001

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 14, 2024

SHMN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sohm

SOHM, Inc. is a healthcare company focused on developing, manufacturing, marketing, and distributing generic and private label pharmaceutical products in the United States. The company offers a diverse range of products, including analgesics, antibiotics, and nutraceuticals, while also engaging in genome editing collaborations.

Products and Services

Generic and private label pharmaceutical products
Analgesics, antibiotics, and anti-inflammatory drugs
Cosmeceuticals and nutraceuticals

Growth Outlook

Collaboration with Coastar Therapeutics enhances innovation in genome editing
Expanding product portfolio to meet increasing market demand
Focus on cost-effective manufacturing to improve margins

Financial Highlights

Recent quarterly revenue of $164,273 shows potential for growth
Gross profit margin of 84.47% indicates strong product profitability
Trailing twelve months (TTM) P/E ratio of 2 suggests undervaluation

AI Generated • Jul 30, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Baron Night

Website

www.sohm.com

Headquarters

Corona, CA 92880, US

SHMN Financials

Key Financial Metrics (TTM)

Gross Margin

76.80%

Operating Margin

-65.87%

Net Income Margin

-66.57%

Return on Equity

-36.42%

Return on Capital

-7.75%

Return on Assets

-10.10%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.44M

Shares Outstanding

2.71B

Volume

120.00K

Avg. Volume

1.92M

Financials (TTM)

Gross Profit

$848.41K

Operating Income

-$727.63K

EBITDA

-$727.63K

Operating Cash Flow

-$522.92K

Capital Expenditure

$4.00

Free Cash Flow

-$522.91K

Cash & ST Invst.

$12.23K

Total Debt

$3.07M

Sohm Performance Analysis

Sohm annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 347,087	6.8%
2023	2023-12-31	USD 402,645	16.0%
2024	2024-12-31	USD 949,032	135.7%
2025	2025-12-31	USD 1,178,844	24.2%

Sohm sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	11.2%
Q3	2025-09-30	41.8%
Q4	2025-12-31	-20.4%
Q1	2026-03-31	-45.1%

Sohm annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD 0.00	0.0%
2023	2023-12-31	USD -0.00	N/A
2024	2024-12-31	USD -0.00	50.0%
2025	2025-12-31	USD -0.00	-33.3%

Sohm sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A
Q4	2025-12-31	-100.0%
Q1	2026-03-31	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$164.27K

-31.1%

Gross Profit

$138.76K

-17.9%

Gross Margin

84.47%

N/A

Market Cap

$2.44M

N/A

Market Cap/Employee

$221.77K

N/A

Employees

N/A

Net Income

-$276.19K

-484.5%

EBITDA

-$269.34K

-476.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$12.23K

-87.2%

Total Debt

$3.07M

-32.9%

Accounts Receivable

$330.74K

+231.9%

Inventory

$314.48K

-35.7%

Long Term Debt

$3.07M

-32.9%

Short Term Debt

$0.00

N/A

Return on Assets

-10.10%

N/A

Return on Invested Capital

-10.90%

N/A

Free Cash Flow

-$432.28K

-581.1%

Operating Cash Flow

-$432.28K

-581.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PLSHPanacea Life Sciences Holdings, Inc.

PLSHPanacea Life Sciences Holdings, Inc.$0.09-2.17%

EVIOEVIO, Inc.

EVIOEVIO, Inc.$0.00+0.00%

HEMPHemp, Inc

HEMPHemp, Inc$0.00+0.00%

KOANResonate Blends, Inc.

KOANResonate Blends, Inc.$0.00+0.00%

BHNGFBhang Inc.

BHNGFBhang Inc.$0.00+0.00%

OWPCOne World Products, Inc.

OWPCOne World Products, Inc.$0.00+0.00%

JWCAFJames E. Wagner Cultivation Corporation

JWCAFJames E. Wagner Cultivation Corporation$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.23+0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.76+0.01%

ONDSOndas

ONDSOndas$9.24+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$140.00-0.01%

INTCIntel

INTCIntel$102.50-0.02%

NVDANvidia

NVDANvidia$225.16-0.00%

NOKNokia

NOKNokia$10.76+0.02%

Questions About SHMN

What is the current price of Sohm?

Sohm is trading at $0.00 per share.

What is the 52-week range for Sohm?

Over the past 52 weeks, Sohm has traded between $0.00 and $0.00.

How much debt does Sohm have?

As of the most recent reporting period, Sohm reported total debt of $3.07M.

How much cash does Sohm have on hand?

Sohm reported $12.23K in cash and cash equivalents in its most recent financial results.

What is Sohm’s dividend yield?

Sohm does not currently have a dividend yield.

Sohm(OTC) SHMN

Sohm Financials at a Glance

SHMN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sohm

SHMN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sohm Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SHMN

What is the current price of Sohm?

What is the 52-week range for Sohm?

How much debt does Sohm have?

How much cash does Sohm have on hand?

What is Sohm’s dividend yield?

Premium Investing Services